FIELD: pharmacology.
SUBSTANCE: invention refers to a method for producing a dosage form of fluorescein disodium salt preparation (2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid disodium salt) used for angiography in neurosurgery and ophthalmology in the form of 5-10% injection. The method consists in the fact that fluorescein disodium salt is produced by neutralising fluorescein in sodium hydroxide with potentiometric and conductometric monitoring of its efficiency. Disodium salt purity is achieved by cleaning both an intermediate product - fluorescein, and fluorescein sodium salt, using a predetermined combination of conventional cleaning procedures at all the process stages.
EFFECT: method enables producing the dosage form of fluorescein disodium salt preparation with using the more simple and environmentally sound process flow that avoids the stages of synthesis and recovery of fluorescein diacetyl derivative to be hydrolysed in a toxic solvent - methanol on boiling.
2 ex, 4 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SUBSTANTIALLY PURE FLUORESCEIN | 2007 |
|
RU2477284C2 |
METHOD FOR PRODUCING PURIFIED ACID BRIGHT BLUE DYE | 2022 |
|
RU2787434C1 |
METHOD FOR QANTITATIVE DETERMINATION OF SODIUM FLUORESCEIN IN SUBSTANCE AND THEREOF-BASED MEDICATION | 2014 |
|
RU2570706C1 |
METHOD FOR SYNTHESIS OF MIXTURE OF ETHYL ESTERS OF IODINATED AND NON-IODINATED FATTY ACIDS FROM VEGETABLE OIL | 2023 |
|
RU2824834C1 |
METHOD FOR PREPARING N-PROPYLAJMALINIUM SALTS WITH CARBOXYLIC ACIDS, STABLE SOLUTION OF N-PROPYLAJMALINIUM HYDROMALONATE AND METHOD FOR ITS PREPARING | 2005 |
|
RU2296765C1 |
METHOD FOR SYNTHESISING DISODIUM SALT OF DEXAMETHASONE 21-PHOSPHATE APPLIED FOR TREATING PATIENTS WITH CORONAVIRUS INFECTION (COVID-19) | 2020 |
|
RU2764597C1 |
METHOD FOR OBTAINING THE DISODIUM SALT OF DEXAMETHASONE 21-PHOSPHATE USED FOR THE TREATMENT OF PATIENTS WITH CORONAVIRUS INFECTION (COVID-19) | 2021 |
|
RU2769195C1 |
METHOD FOR PREPARING SODIUM MONOSIALIC GANGLIOSIDE AND NEUROPROTECTIVE AGENT BASED ON IT | 2016 |
|
RU2632710C2 |
METHOD OF PURIFYING ALL-E- OR 130-VITAMIN ACHO-ACID | 1992 |
|
RU2022962C1 |
METHOD FOR PRODUCING AN ANTI-INFLAMMATORY AGENT BASED ON MAMMALIAN SPLEEN PEPTIDES, AGENT PRODUCED THEREBY AND APPLICATION THEREOF | 2021 |
|
RU2790158C1 |
Authors
Dates
2016-01-20—Published
2014-07-22—Filed